ET-09 ACQUIRED MALIGNANT BEHAVIORS OF NPE6-PDT-SURVIVED GLIOBLASTOMA CELLS ARE SUPPRESSED BY USING MEK1/2 INHIBITOR TRAMETINIB

INTRODUCTION: In this study, we tried to investigate alteration of oncogenic properties and their molecular regulatory mechanism of talaporfin sodium (NPe6)-mediated photodynamic therapy (NPe6-PDT)-survived glioblastoma (GBM) cells. METHODS: As the in-vitro NPe6-PDT model, human GBM cell lines (T98G...

Descripción completa

Detalles Bibliográficos
Autores principales: Kobayashi, Tatsuya, Muragaki, Yoshihiro, Takahashi, Masamichi, Wada, Kojiro, Mori, Kentaro, Kawamata, Takakazu, Ichimura, Koichi, Tomiyama, Arata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213242/
http://dx.doi.org/10.1093/noajnl/vdz039.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213242/
http://dx.doi.org/10.1093/noajnl/vdz039.040

Ejemplares similares